News about spin-off

Jim Cramer's Charitable Trust is selling 58 DuPont (DD) shares at roughly $143 each. After Monday's trade, the trust holds 450 DD shares, cutting its portfolio weight to 1.65% from 1.85%. The small trim offsets an earlier Boeing (BA) purchase that day. DuPont shares are up about 10% since late September, helped by rotation out of data center buildout names, but remain about $12 below their 2026 peak and are up about 18% year to date. The author says the simplification story has largely played out a year after the Qnity Electronics separation, with shares up about 36% since the breakup. The sale will realize a gain of roughly 48% on shares bought in August 2023, and the author will watch DuPont's earnings before Tuesday's open.

Medtronic has raised its quarterly dividend for 49 consecutive years, one year short of Dividend King status, which requires 50 years. At an annualized dividend of $2.88 per share, roughly 348 shares, costing about $32,792, would generate $1,002.24 in annual dividend income, a yield of around 3%. Recent dividend increases have been modest, at 1.4% this year and an average of 2% over three years. The spinoff of MiniMed, its lower-margin diabetes business, completed via an exchange offer this week, lets Medtronic focus on its higher-margin cardiovascular, neuroscience and surgical businesses. Analysts estimate earnings growth of 8.1% and 7.1% for the fiscal years ending January 2027 and January 2028, and with a 48% forward payout ratio, that could support larger dividend increases.